Sequential magnetic resonance imaging follow-up of multiple sclerosis before the clinical phase

Abstract

There is much evidence of the importance of the preclinical phase of multiple sclerosis (MS). However, apart from a recent report of the incidental discovery of a case of primary progressive MS, there are no data on the sequential magnetic resonance imaging (MRI) follow-up of patients before the clinical phase. We report the incidental discovery of white matter changes on MRI and their follow-up in a patient three years before the first neurological event (optic neuritis). A 34-year-old woman presented with headaches and depression after her young daughter had been involved in a car accident and spent two weeks in intensive care. The woman’s general practitioner performed a brain MRI, which revealed multiple T2-weighted hypersignals suggesting MS. During the next three years, clinical examination remained normal but we observed new T2 lesions and/or new enhanced T1 lesions after gadolinium infusion on the four successive MRIs. Thirty-seven months after the first MRI, the patient developed a right optic neuritis. The diagnosis of MS was made according to space and time dissemination on MRI criteria. We proposed a treatment with Interferon Beta 1a (Avonex).

Keywords

early treatment MRI multiple sclerosis optic neuritis preclinical subclinical

Get full access to this article

View all access options for this article.

References

McDonnell GV , Cabrera-Gomez J , Calne DB , Li DKB , Oger J. Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions . Mult Scler 2003; 9: 204-209 .

Gilbert JJ , Sadler M. Unsuspected multiple sclerosis . Arch Neurol 1983; 40: 533-536 .

Herndon RM , Rudick RA. Multiple sclerosis. The spectrum of severity . Arch Neurol 1983; 40: 531-532 .

Tienari PJ , Salonen O , Wikstrom J , Valanne L , Plao L. Familial multiple sclerosis: MRI findings in clinically affected and unaffected siblings . J Neurol Neurosurg Psychiatry 1992; 55: 883-886 .

Lynch SG , Rose JW , Smoker W , Petajan JH. MRI in familial multiple sclerosis . Neurology 1990; 40: 900-993 .

Sadovnick AD , Armstrong H , Rice GP , Bulman D , Hashimoto L , Paty DW et al. A population-based study of multiple sclerosis in twins: update . Ann Neurol 1993; 33: 281-285 .

Thorpe JW , Mumford CJ , Compston DA , Kendall BE , MacManus DG , McDonald WI et al. British Isles survey of multiple sclerosis in twins: MRI . J Neurol Neurosurg Psychiatry 1994; 57: 491-496 .

McDonald WI , Compston A , Edan G , Goodkin D , Hartung HP , Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis . Ann Neurol 2001; 50: 121-127 .

Miller DH. Magnetic resonance in monitoring the treatment of multiple sclerosis . Ann Neurol 1994; 36 (Suppl): S91-S94 .

10.

Jacobs LD , Beck RW , Simon JH , Kinkel RP , Brownscheidle CM , Murray TJ et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group . New Engl J Med 2000; 343: 898-904 .